AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors (IMAGE)
Caption
Corresponding author Samuel Brady, PhD, St. Jude Department of Pharmacy & Pharmaceutical Sciences.
Credit
St. Jude Children's Research Hospital
Usage Restrictions
No cropping
License
Original content